Basics of Benzodiazepine Use Disorder. DATE: March 20, 2018 PRESENTED BY: Melissa B. Weimer, DO, MCR

Similar documents
Basics of Benzodiazepine Use Disorder. DATE: June 12, 2018 PRESENTED BY: Melissa B. Weimer, DO, MCR

Basics of Benzodiazepine Use Disorder. DATE: October 3, 2017 PRESENTED BY: Melissa B. Weimer, DO, MCR

MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER Melissa B. Weimer, DO, MCR Chief of Behavioral Health & Addiction Medicine St.

WHEN AND HOW TO USE BENZODIAZEPINES IN TREATING ANXIETY: AM I WITHHOLDING TREATMENT IF I DON'T USE BENZODIAZEPINES?

MEDICATION ALGORITHM FOR ANXIETY DISORDERS

Medications For Alcohol Use Disorder

Treatment of Anxiety (without benzos)

Strategies in Managing Opioid and Benzodiazepine Co-Prescribing

Using Benzodiazepines in Primary Care

Anxiety Pharmacology UNIVERSITY OF HAWAI I HILO PRE -NURSING PROGRAM

Benzodiazepines: Comparative Effectiveness and Strategies for Discontinuation. Ann M. Hamer, PharmD, BCPP Rural Oregon Academic Detailing Project

Managing presenting problems with benzodiazepines. By Dr Gideon Felton MRCPsych Consultant Psychiatrist and Clinical Lead

WHAT SHOULD WE DO ABOUT BENZODIAZEPINES? Miriam Komaromy, MD Associate Director, Project ECHO August 2014

ANXIETY: FAST FACTS AND SKILLS FOR THE PRIMARY CARE PHYSICIAN

Vistaril ( hydroxyzine ) is a non-addictive antihistamine medication. This drug is used to relieve the itching caused by allergies and to control the

Benzodiazepines. Benzodiazepines

ten questions you might have about tapering (and room for your own) an informational booklet for opioid pain treatment

For: NEON Primary Healthcare Providers By: Michelle Romero, DO June 2013

Treating Anxiety Disorders. Adil Virani, BSc (Pharm), Pharm D, FCSHP

COMMONLY PRESCRIBED PSYCHOTROPIC MEDICATIONS NAME Generic (Trade) DOSAGE KEY CLINICAL INFORMATION Antidepressant Medications*

Practical Tools to Successfully Taper Prescription Opioids. Melissa Weimer, DO, MCR

Difficult Conversations

Identification and Management of Benzodiazepine and Z-drug abuse

Marijuana. DATE: June 26, 2018 PRESENTED BY: Melissa Weimer, DO, MCR, FASAM

Anxiety Disorders.

Mixing and Matching: Layering Medications as Family Physicians

Sedative / Hypnotics

Anxiolytic, Sedative and Hypnotic Drugs. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

BENZODIAZEPINES: WHAT YOU DON T KNOW CAN HURT YOU

Disclosures. Objectives. Symptoms of fear. The Fifteen Minute Hour: Psychotherapy & Medications for Anxiety Management in Primary Care 4/5/18

Session 2: Mental Health A: Alcohol Dependency: The Pharmacist s Role in Detox and Treatment 1:45pm - 2:45pm

Can klonopin help withdrawal opiates

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

Pharmacotherapy of Anxiety Disorders (GAD, Panic, & SAD) Declaration of Interests

Multiple Choice Questions

ALCOHOL USE DISORDER WITHDRAWAL MANAGEMENT AND LONG TERM TREATMENT ANA HOLTEY, MD ADDICTION MEDICINE FELLOW UNIVERSITY OF UTAH HEALTH

Sedatives and Hypnotics. Ahmad Al-Tarifi. Zahra Khalil. Pharmacology. 1 P a g e

Antidepressant Medication Therapy in Primary Care July 25, 2013

SCENARIOS IN SUBSTANCE MISUSE. By Dr Gideon Felton Consultant Psychiatrist and Clinical Lead

Disclosures. Overview of Workshop. Objectives. Medical Care of Vulnerable and Underserved Populations: Advanced Cases in Anxiety and Depression

11/1/2010. Psychology 472 Pharmacology of Psychoactive Drugs. Listen to the audio lecture while viewing these slides

An algorithm for medication in the treatment of Complex PTSD

ROLE OF HEALTH CARE PROVIDERS IN THE MANAGEMENT OF ALCOHOL AND DRUG USE RELATED PROBLEMS

Tapering Opioids Best Practices*

Soma (carisoprodol), Soma Compound (carisoprodol and aspirin), Soma Compound w/ Codeine (carisoprodol and aspirin and codeine)

Prepared by: Dr. Elizabeth Woodward, University of Toronto Resident in Psychiatry

some things you should know about opioids before starting a prescription an informational booklet for opioid pain treatment

Depression & Anxiety in Adolescents

BOOTS ON THE GROUND CRUCIAL CONVERSATIONS RELATED TO MEDICATION TAPERING

Anxiolytic & Hypnotic Drugs. Asst Prof Dr Inam S Arif

Treating Pain and Depression

OLDER ADULTS & DEPRESCRIBING: TREATMENT

Benzodiazepines. CRIT program May Alex Walley, MD, MSc Assistant Professor of Medicine Boston University School of Medicine

Soma (carisoprodol), Soma Compound (carisoprodol and aspirin), Soma Compound w/ Codeine (carisoprodol and aspirin and codeine)

PSYCHIATRIC MANAGEMENT IN PRIMARY CARE. Dr Fayyaz Khan MBBS, MRCPsych, MSc Consultant Psychiatrist (Locum) Mersey Care NHS Trust

8/15/17. Managing Psychiatric Conditions in Primary Care Beyond the Basics. Speaker s Biography. Situation

USUAL DOSE OF XANAX. Usual Dose Of Xanax

Tapering off ativan.5

Current Clinical Patterns in the Management of Alcohol Withdrawal Syndrome (AWS)

Dr Chris Ford Clinical Director IDHDP (International Doctors for Healthy Drug Policies) Thursday 16 th May 2013

Mental Health Nursing: Anxiety Disorders. By Mary B. Knutson, RN, MS, FCP

Dr. Oslin receives grant support from the NIH, VA, and the Pennsylvania Department of Aging.

Psychiatric Medication Guide

MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER

VA/DoD Clinical Practice Guideline for Management of Post Traumatic Stress. Core Module

Benzodiazepines Information for GPs

What You Need to Know About Benzodiazepines & Other Anxiety Drugs

Reducing the Anxiety of Pediatric Anxiety Part 2: Treatment

Medications Guide: Public Speaking And Social Anxiety

Co-Occurring Mental Health and Substance Use Disorders. DATE: 4/17/18 PRESENTED BY: John Mahan, MD

Opioid Use Disorder Treatment: Buprenorphine Treatment Basics

Treatment of Alcohol and Opiate Withdrawal

DRUGS USED IN THE TREATMENT OF ADDICTION JOSEPH A. TRONCALE, MD FASAM RETREAT PREMIERE ADDICTION TREATMENT CENTERS

ANTICONVULSANTS IN ALCOHOL WITHDRAWAL TREATMENT: A BETTER WAY?

Buprenorphine 2.0: I have my waiver, now what? Dr. Ritu Bhatnagar, M.D., M.P.H. Dr. John Ewing, M.D., FASAM. Disclosures

Managing Pain in the Patient with Opioid Use Disorder: Inpatient Management. Melissa Weimer, DO, MCR Oregon Health & Science University

Acute General Medical and Surgical Admission:

Tranquilizers & Sedative-Hypnotics

FROM MEDICATION TO MINDFULNESS: NEW INSIGHTS INTO THE WORLD OF ANXIETY

Substance Misuse and Abuse

Anxiety: Cure For Anxiety, Fear, Panic & Techniques For Stress By Zac Dixon READ ONLINE

Withdrawal.

Pharmacological Treatment of Anxiety & Depressive Disorders

Friend or Foe? Review of the Regulations & Benefits: Risk Profiles of the Benzodiazepines

THEXANAX THREAT 1 THE XANAX THREAT. iaddiction.com

Psychopharmacology in the Emergency Room. Michael D. Jibson, M.D., Ph.D. Associate Professor of Psychiatry University of Michigan

Major Depression and Anxiety in Adolescents and Adults

GUIDELINES FOR THE USE OF PSYCHOACTIVE MEDICATIONS IN INDIVIDUALS WITH CO-OCCURRING SUBSTANCE USE DISORDERS

Canadian Guideline for Opioids for Chronic Non-Cancer Pain. Speaker Disclosure. Objectives. Canadian Guideline for Opioids for Chronic Non-Cancer Pain

1/20/2017. Benzodiazepines Overuse. Pharmacist Objectives. Technician Objectives. A Bit of History. Benzodiazepines: Mechanism of Action

Managing presenting alcohol users an Introduction to SPECTRUM (CRI) By Dr Gideon Felton MRCPsych Consultant Psychiatrist and Clinical Lead

Alcohol Use in the Elderly

Anxiety Disorders: First aid and when to refer on

Assessing and Treating Cooccurring

DRUGS THAT ACT IN THE CNS

Presenter Disclosure. Objectives 6/5/2017. Depression, Anxiety, PTSD: A Focus on Pharmacotherapy

Guidelines for the In-Patient Management of Alcohol Withdrawal at Frimley Park Hospital NHS Foundation Trust

CHILDHOOD/ADOLESCENT ANXIETY DISORDERS: EVALUATION AND TREATMENT

Universal Precautions and Opioid Risk. Assessment. Questions: How often do you screen your patients for risk of misuse when prescribing opioids?

6/27/2017. Disclosures. Overview. Case Overview

Transcription:

Basics of Benzodiazepine Use Disorder DATE: March 20, 2018 PRESENTED BY: Melissa B. Weimer, DO, MCR

Disclosures Speaker: Melissa Weimer, DO, MCR, has nothing to disclose. Planning Committee: The members of the planning committee (Jessica Gregg, Todd Korthuis, Melissa Weimer, John Mahan, Laura Heesacker, O Nesha Cochran, and Chris Colasurdo) have nothing to disclose. 2 2

Objectives Understand the mechanism of action and pharmacokinetic properties of benzodiazepines Understand that differentiating between benzodiazepine physiologic dependence and benzodiazepine use disorder may be challenging Describe how to safely taper benzodiazepine therapy 3 3

Benzos are positive allosteric modulators Increase the GABA A receptor s affinity for GABA

Acute Withdrawal Symptoms: occur after 10-21 days Symptom Frequency Insomnia 71% Anxiety 56% Mood swings 49% Muscle twitching 49% Tremor 38% Headache 38% Nausea, vomiting, anorexia 36% Hypersensitivity to smells, sounds, lights, noise, touch Up to 38% Seizure 4% Jahnsen, 2015 https://www-ncbi-nlm-nih-gov.liboff.ohsu.edu/pmc/articles/pmc4318457/pdf/dtsch_arztebl_int-112-0001.pdf

Features of a Benzo Use Disorder vs Benzo physiologic dependence Tolerance Withdrawal When severe, these 2 issues can cause problems with their life, ability to cope Benzo dependence alone Benzo use disorder Tolerance Withdrawal Loss of control of use Continued use despite social or interpersonal issues related to use Giving up other activities due to use No longer fulfilling major life obligations Consistent use despite acknowledgement of harms Wanting to cut down, but not being able Taking in larger amounts and longer than intended

Case Example 1 Real case Joe is a 72 yo man with HTN and hyperlipidemia. He developed severe anxiety after retirement approximately 10 years ago and was prescribed lorazepam 1mg BID. He found it helped him at first, but now he feels like it is a crutch and he doesn t like the effect his wife says it has on him. He would like to stop the medication but every time he stops, he becomes sweaty, fearful, anorexic and can not sleep. He would like to stop the medication before he goes on a cruise in 10 days. He has been erratically taking his meds over the last 2 weeks in an attempt to stop them, but has not been able to sleep and feels horrible.

Features of a Benzo Use Disorder vs Benzo physiologic dependence Tolerance Withdrawal Benzo dependence alone Benzo use disorder Tolerance Withdrawal Loss of control of use Continued use despite social or interpersonal issues related to use Giving up other activities due to use No longer fulfilling major life obligations Consistent use despite acknowledgement of harms Wanting to cut down, but not being able Taking in larger amounts and longer than intended

Taper plan Enjoy your vacation on a stable dose of lorazepam 1mg BID Start benzodiazepine taper when you return Consider transition to clonazepam or diazepam http://www.globalrph.com/benzodiazepine_calc.htm Taper by 10-25% per week depending on how well patient tolerates each step of the taper and dose availability Start mirtazapine and melatonin for sleep Create sleep routine and cut out naps Refer for cognitive behavioral therapy (CBT) Find hobbies or volunteer work

Case Example 2 Real case Joanne is a 52 year old female with hx of PTSD and major recurrent depression who seeks care in your primary care clinic for help getting off of benzos. She has been prescribed benzos (diazepam) since age 20 and has tried several times to stop them. She has developed a social phobia about psychiatrists. She can not go longer than 4 hours between doses or she has severe panic, though she does not take them more than prescribed to her. She has completely isolated herself from family and friends, can not work and feels completely disabled. Her friend recently drove to FL to pick her up because she was so distraught over her use and inability to stop benzodiazepines and her current prescriber is threatening to cut her off. She desperately wants to stop and her friend plans to help her and support her.

Features of a Benzodiazepine Use Disorder vs Benzodiazepine dependence Benzo physiologic dependence Tolerance Withdrawal Benzo use disorder Tolerance Withdrawal Loss of control of use?? Continued use despite social or interpersonal issues related to use Giving up other activities due to use No longer fulfilling major life obligations Consistent use despite acknowledgement of harms Wanting to cut down, but not being able Taking in larger amounts and longer than intended

Taper plan: prolonged taper Stabilize patient over 1-2 weeks on a dose of long acting benzodiazepines (clonazepam) mostly equivalent to her current prescription for diazepam Care coordinate with her friend to help manage medication and inform you if there are any issues Keep a log and lock on the medications Consider inpatient treatment if this doesn t go well Start very slow taper by reducing clonazepam by 0.25mg every 2 weeks Add propranolol due to patient avoidance of all other meds Taper takes 1 year and is successful Patient engages in NA meetings for support

Case 3: REAL case Jimmy is a 22 year old man with hx of tobacco use who has been ordering a research benzodiazepine (etizolam) from CA for the last year. Total dose of 20mg per day. He also drinks a 6 pack of beer per day. He has received a DWI due to driving while intoxicated. He has had 2 seizures in the past due to attempting to taper his use on his own. He feels restless, anxious, sweaty, and continual vomiting. He would like to get back to work for the parks service as soon as possible. His parents have threatened to kick him out of the house if he does not stop his use.

Features of a Benzo Use Disorder vs Benzo physiologic dependence Tolerance Withdrawal Benzo dependence alone Benzo use disorder Tolerance Withdrawal Loss of control of use Continued use despite social or interpersonal issues related to use Giving up other activities due to use No longer fulfilling major life obligations Consistent use despite acknowledgement of harms Wanting to cut down, but not being able Taking in larger amounts and longer than intended

Taper plan Inpatient admission for detoxification Start Depakote 250mg TID, continue 3 weeks Schedule Librium 50-100mg QID x 1 day and then reduce by 25-50mg per day depending on time in detox Fastest inpatient taper = 5-7 days Longest inpatient taper = 10-14 days Continue PRN Librium based on CIWA scale as well Work with family on safe discharge plan Advise against working or driving for the next week, minimum Start hydroxyzine, buspirone, trazodone to help with symptom relief Refer for treatment

Alternatives to Benzos for anxiety Gabapentin Prazosin or Clonidine Propranolol Quetiapine Mirtazepine SSRIs Hydroxyzine Buspirone List is not in order of preference and not an exhaustive list Always choose a medication best suited for the specific problem you are attempting to address Consider TRAUMA and PTSD

Withdrawal Management Soyka, 2017 4-8 weeks to taper, maybe longer, but not too long 10-50% in first week Hospitalize if > 100mg diazepam equivalents Don t withdraw opioids at the same time Adjuncts: gabapentin, carbamazepine or depakote, SSRIs, TCAs, antihistamines (i.e. hydroxyzine), melatonin Limited evidence for AEDs, but still consider

Withdrawal Management Calculate benzodiazepine equivalency (http://www.globalrph.com/benzodiazepine_calc.htm) Reduce by 25-30% per day or week, depending on time course Create taper plan based on Time in detox Ability to safely assure taper and monitor patient Other risk factors like opioid use, alcohol use, etc Adjuvant meds Carbamazepine 200mg BID or Divalproic Acid 250mg TID Vistaril 25-50mg QID Buspar 5-10mg TID Trazodone for sleep Consider one of the following: clonidine or prazosin or propranolol

References http://www.globalrph.com/benzodiazepine_calc.htm Soyka, Treatment of Benzodiazepine Dependence. NEJM 376; 12. March 23, 2017 http://www.oregonpainguidance.org/app/content/uploads/2016/ 05/Opioid-and-Benzodiazepine-Tapering-flow-sheets.pdf

Benzodiazepine Metabolism Glucuronide Conjugation o Shorter half-life o Inactive metabolites o Safer in liver disease and elderly Lorazepam Oxazepam Temazepam (remember LOT) Oxidation o Longer half-life o More metabolites o Use caution in liver disease Chlordiazepoxide Diazepam Clonazepam